Effective October 1, 2015, the Board of Anavex Life Sciences Corp. has appointed Sandra Boenisch, to serve as the company's Principal Financial Officer until the earlier of a successor's appointment or her resignation. Ms. Boenisch is a Chartered Professional Accountant (CPA, CGA) with 14 years of accounting, audit, and financial reporting experience in a variety of industries, both in the United States and Canada.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.11 USD | +2.24% | +0.98% | -55.85% |
05-22 | Sector Update: Health Care Stocks Slightly Higher Late Afternoon | MT |
05-22 | Anavex Life Sciences Expands Leadership Team; Shares Rise | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-55.85% | 340M | |
+16.73% | 121B | |
+13.04% | 107B | |
-5.80% | 24.82B | |
+1.69% | 22.48B | |
-10.09% | 18.32B | |
-40.52% | 16.33B | |
-14.00% | 15.31B | |
+1.18% | 14.08B | |
+24.18% | 11.74B |
- Stock Market
- Equities
- AVXL Stock
- News Anavex Life Sciences Corp.
- Anavex Life Sciences Corp. Appoints Sandra Boenisch to Serve as the Principal Financial Officer